News
San Francisco Office

Avalanche Takes Full Occupancy in Menlo Park

Avalanche Biotechnologies just took 100% occupancy at 1035 O’Brien Dr in Menlo Park, leasing the remaining 36k SF at the Tarlton Properties' building. Founded in 2006, Avalanche is a clinical-stage biopharmaceutical company committed to improving or preserving the sight of people suffering from blinding eye diseases. Avalanche’s lead product candidate, AVA-101, is in mid-stage clinical development.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's San Francisco Newsletters
Related Stories

JVP Development Is Betting $37M Of Its Own Money That Frisco Is Ready For Spec Office

Hedge Fund Bids $88M For Spirit Airlines' Former HQ

Oyster Point's Second Phase Half-Leased As Kilroy Navigates Soft Lab Demand

BXP Closes In On Next D.C. Office Development As It Shrinks Assets

Clarion Under Contract To Sell 18-Story Seaport Office Tower

Oil Company Expands Again At Cash Register Building

BXP's 343 Madison Lands $1.2B Loan, Nears Deal With Equity Partner

D.C. Sues To Block HUD Headquarters Move To Virginia

Ken Griffin Completes Takeover Of Brickell Block, Setting Stage For $2.5B Megaproject

Private Equity Firm Buys Former Texas Instruments Campus For New Headquarters

DFW Office Footprints Likely To Shrink As AI Use Increases And Companies Battle For Talent

Boston Waterfront Property Planned For Hotel Project Put Up For Sale